| Ytd | -72.85% | |
| 1y | -55.58% |
| Open | 7.48 | Prev Close | 7.44 | Low | 7.36 | High | 7.52 | Mkt Cap | 400.53M |
| Vol | 12.60K | Avg Vol | 618.03K | EPS | -2.91 | P/E | -2.53 | Forward P/E | -2.45 |
| Beta | 1.26 | Short Ratio | 2.45 | Inst. Own | 94.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 6.89 | 200-d Avg | 15.52 | 1yr Est | 47.86 |
Sanofi reports positive Phase 2 data for lunsekimig in asthma and nasal polyps, while atopic dermati
U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of pu